Ryuji Okuyama
Ryuji Okuyama publishes mostly in Oncology, Immunology and Molecular Biology, on topics such as Immunotherapy and Immune Responses, Colorectal Cancer Treatments and Studies and Cholangiocarcinoma and Gallbladder Cancer Studies.
- World rank
- #3,832,706 of 7,710,434 ranked researchers
- Rank in Japan
- #99,665 of 383,136
- Works
- 27
- Citations
- 541
- Citations per work
- 20.0
What does Ryuji Okuyama research?
Ryuji Okuyama's work is mostly in Medicine (40%), Immunology and Microbiology (20%), Biochemistry, Genetics and Molecular Biology (18%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1140.0%
- Medicine1140.0%
- Life Sciences1038.2%
- Everything else621.8%
- 1Oncology24% of their works
- 2Immunology20% of their works
- 3Molecular Biology13% of their works
- 4Surgery11% of their works
- 5Pulmonary and Respiratory Medicine6% of their works
- 6Cancer Research6% of their works
Research topics
- Immunotherapy and Immune Responses
- Colorectal Cancer Treatments and Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- vaccines and immunoinformatics approaches
- Gastric Cancer Management and Outcomes
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Cancer Immunotherapy and Biomarkers
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe Ryuji Okuyama's research?
The keywords of their largest research topics: Antigen Presentation, Immunity, Chemotherapy, Cancer Immunotherapy, Dendritic Cells, Cetuximab, KRAS Mutations and Biliary Tract Cancer.
- Reactive Oxygen Species
- Neutrophil Extracellular Traps
- Fc Receptors
- Gastric Cancer
- Endoscopic Resection
- Biliary Tract Cancer
- Cetuximab
- Cancer Immunotherapy
- Immunity
- Antigen Presentation
- Chemotherapy
- Dendritic Cells
- KRAS Mutations
- Cholangiocarcinoma
- Epitope Prediction
- Peptide-MHC Binding
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Therapeutic Antibodies
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Antigen Presentation102 topics
- Immunity92 topics
- Chemotherapy82 topics
- Cancer Immunotherapy71 topic
- Dendritic Cells71 topic
- Cetuximab51 topic
- KRAS Mutations51 topic
- Biliary Tract Cancer41 topic
- Cholangiocarcinoma41 topic
- Endoscopic Resection31 topic
- Epitope Prediction31 topic
- Gastric Cancer31 topic
- Peptide-MHC Binding31 topic
- Fc Receptors21 topic
- Immune Checkpoint Blockade21 topic
- Neutrophil Extracellular Traps21 topic
- PD-1 and PD-L121 topic
- Reactive Oxygen Species21 topic
- Therapeutic Antibodies21 topic
Where does Ryuji Okuyama work?
Ryuji Okuyama's main affiliation in the publication record is Tokyo Women's Medical University, Japan.
How many publications and citations does Ryuji Okuyama have?
OpenAlex counts 27 works and 541 citations for Ryuji Okuyama, an h-index of 10, ranking #3,832,706 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ryuji Okuyama. Posts are plain text and can be reported.